Pharminent

IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery

ARMONK, N.Y. and NEW YORK, Dec. 1, 2016 /PRNewswire/ — IBM (NYSE: IBM) Watson Health and Pfizer Inc. (NYSE: PFE) today announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer’s research in immuno-oncology, an approach to cancer treatment that us… http://www.prnewswire.com/news-releases/ibm-and-pfizer-to-accelerate-immuno-oncology-research-with-watson-for-drug-discovery-300371187.html

Filed under: Cancer, Immunotherapy